SCHEMBL2730182

SCHEMBL2730182

Cc1cnc(N2CCC3(CCCN(Cc4c[nH]c5ccccc45)C3)CC2)nc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.59
HDAC1 Q13547 1/20 0.59
HDAC2 Q92769 1/20 0.59
HDAC8 Q9BY41 1/20 0.59
HDAC6 Q9UBN7 1/20 0.59
NCOR2 Q9Y618 1/20 0.59
HCRTR2 O43614 11/20 0.53
HCRTR1 O43613 10/20 0.53
LMNA P02545 3/20 0.48
HTT P42858 3/20 0.48
POLB P06746 1/20 0.48
TSHR P16473 1/20 0.48
KDM4E B2RXH2 1/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
DRD3 P35462 1/20 0.46
HTR1A P08908 1/20 0.46
TSPO P30536 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2732669 0.84 HCRTR2 (0.56) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL2132263 0.80 HCRTR2 (0.77) HCRTR2HCRTR1HTR1ATSPO
SCHEMBL2026886 0.77 HCRTR2 (0.60) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL9949405 0.76 HCRTR2 (0.55) HCRTR2HCRTR1HTR1ATSPO
SCHEMBL12501032 0.76 HCRTR2 (0.53) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL2732768 0.75 HCRTR2 (0.49) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL2027574 0.74 HCRTR1 (0.67) HDAC3HDAC1HDAC2HDAC8HDAC6
Hydrochloric Acid SCHEMBL28613856 0.74 HDAC3 (1.00) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL2129153 0.72 HCRTR2 (0.74) HCRTR2HCRTR1HTR1ATSPO
SCHEMBL2026825 0.71 HCRTR2 (0.69) HDAC3HDAC1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2632924-A1 DIAZA-SPIRO[5.5]UNDECANES USEFUL AS OREXIN RECEPTOR ANTAGONISTS Novartis AG (CH) 2013-09-04 EP disclosed
WO-2012055888-A1 DIAZA-SPIRO[5.5]UNDECANES USEFUL AS OREXIN RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 2012-05-03 WO disclosed